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Abstract Cyclophilins (CyPs) are binding proteins for the 
immunosuppressive drug cyclosporin A (CsA). CyPs are 
evolutionarily highly conserved proteins present in both pro- 
and eukaryotes as well as in different snbeellular locations. CyPs 
possess enzymatic activity, namely peptidyl-prolyl cis-trans 
isomerase (PPIase) activity; CyPs are involved in cellular 
protein folding and protein interactions. To date, only cyelospor- 
ins and proteins are known to interact with CyPs. Here we 
describe a novel nuclear cyclophilin (hCyP33) from human T 
cells with an additional RNA-binding domain. This combines for 
the first time RNA binding and protein folding in one protein. 
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for the first time RNA binding and protein folding in one 
protein. 
2. Material and methods 
2.1. Cloning of a full-length eDNA for hCyP33 
PCR amplification fDNA-fragments from different human Jurkat 
T cell line cDNA libraries were performed with two degenerate pri- 
mers, which correspond to amino acid sequences QGGDF and 
KHVVFG (boxed in Fig. 2b) in the highly conserved regions of 
known cyclophilins [3,13,17-20]. The resulting PCR products were 
subcloned into pUC18 and sequenced. Nested PCR was performed 
to extend the sequence using two libraries: aMarathon cDNA library 
of the human Jurkat T cell line (Clontech) and a cDNA library made 
of mRNA from human T cells. Both libraries yielded as longest 
cDNA one with a length of 1.6 kb. The eDNA was sequenced on 
both strands. 
1. Introduction 
Cyclophilins (CyPs) are highly conserved proteins present in 
both pro- and eukaryotes and in different subcellular locations 
[1-3]. Besides their high-affinity binding of cyclosporin A 
(CsA), CyPs possess peptidyl-prolyl cis-trans isomerase 
(PPIase) activity, which is inhibited by CsA. Due to the 
PPIase activity CyPs are able to accelerate protein folding 
in vitro (reviewed in [2,3]). There is increasing evidence that 
CyPs are involved in cellular protein folding after ribosomal 
synthesis and after passage of proteins across intracellular 
membranes [4-8]. CyPs are also involved in transient protein 
interactions, e.g. with steroid receptors [9], gag protein of HIV 
[10,11], or rhodopsin [12]. Abundant cytosolic CyPs (hCyP18 
in human cells [13] and NcCyP20 [14] in the fungus Neuro- 
spora crassa) mediate the immunosuppressive [15] or antifun- 
gal effect [16], respectively, of CsA by inhibiting the protein 
phosphatase calcineurin. 
In higher eukaryotic ells a variety of CyPs are present in 
different concentrations and cellular compartments. Abundant 
small forms (18-24 kDa) are present in the cytosol, mitochon- 
dria and the endoplasmic reticulum, perhaps being part of the 
protein folding machinery [4-8]. Larger CyPs (40~360 kDa) 
containing additional protein-binding domains are present in 
hormone receptor complexes [9], nuclear pores [17] or on the 
cell surface [18]. To date, two kinds of molecules are known to 
interact with CyPs: cyclic peptides (eyclosporins) and pro- 
teins. 
Here we describe a novel nuclear cyclophilin (hCyP33) from 
human T cells, hCyP33 contains two functional domains: an 
RNA-binding domain at the amino-terminus and a PPIase 
domain at the carboxy-terminus of the protein. This combines 
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The amino acid sequence for hCyP33 has been deposited under MIPS 
accession number $66681. 
2.2. Detection of hCyp33 mRNA using Northern hybridization 
Human Jurkat T cell poly(A) + RNA (2 lag per lane) was resolved 
on a formaldehyde g l, blotted onto a nylon membrane and hybrid- 
ized as described [14]. 
Jurkat T cells were subfractionated according to [21]. A hCyP33- 
specific rabbit antiserum was obtained by immunization with a glu- 
tathione transferase-fusion protein [22] containing amino acids 67 164 
of hCyP33 at the carboxy-terminus. 
2.3. In vitro expression 
A full-length cDNA coding for hCyp33 was subcloned into 
pGEM4. Coupled in vitro transcription/translation usi g ass-labeled 
methionine was performed in a TNT SP6 coupled reticulocyte lysate 
system (Promega) according to the manufacturer's protocol. 
Nucleic acid binding assays were performed using aSS-labeled 
hCyP33 from the in vitro expression system (see Fig. 4a, lane 1) as 
described [23]. 
PPIase assays were performed ina standard peptide assay [24] using 
a GST-hCyP33 fusion protein and Suc-Ala-Ala-Pro-Phe-pNA asa 
substrate. 
3. Results 
A variety of different cyclophilins have been cloned from 
higher eukaryotic ells (reviewed [1-3]). Using a CsA affinity 
column, we recognized minor bands in addition to the known 
CyPs (unpublished data). We therefore used a PCR approach 
to identify new CyPs from the human T cell line Jurkat. 
Degenerate primers directed against regions which are highly 
conserved in known CyPs (QGGD and KHVVFG; see boxes 
in Fig. 2b) were used to amplify short DNA fragments from 
different Jurkat eDNA libraries, Ninety CyP-related cDNA 
fragments were cloned and sequenced. Sixty-nine clones 
were identified as part of the coding region of human 
CyP18 [13], 19 were identical to secretory hCyP23 [19], one 
was identical to mitochondrial hCyP22 [20] and one clone 
(M1) represented a new hCyP. Using additional PCR ap- 
proaches extending the eDNA sequence (5'- and 3'-RACE) 
to identify a full-length cDNA, we finally isolated and se- 
quenced a 1.6 kb cDNA. This cDNA codes for a protein of 
33 430 Da, which was named hCyP33. 
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Fig. 1. hCyP33 contains an RNA-binding domain at the amino-ter- 
minus and a cyclophilin domain at the carboxy-terminus, a: Amino 
acid sequence of hCyP33 derived from the cDNA. b: Domain or- 
ganization of hCyP33. 
Fig. la shows the amino acid sequence of hCyP33 derived 
from the cDNA sequence. Sequence databank comparisons 
revealed that hCyp33 is a novel protein. Surprisingly, the 
protein exhibits two regions of high sequence identity to other 
proteins. The first region showed similarities to cyclophilins, 
as expected, whereas the second region was similar to RNA- 
binding proteins containing an RNA recognition motif 
(RRM, also known as RNA-binding domain or RNP consen- 
sus sequence; reviewed in [25-27]). 
Separate sequence alignments of both domains are shown in 
Fig. 2. The putative amino-terminal RNA-binding domain of 
hCyP33 contains both RNP-1 and RNP-2 submotifs (Fig. 2a) 
located 33 amino acids apart. The RNP-1 octapeptide, Lys/ 
Arg-Gly-Phe/Tyr-Gly/Ala-Phe-Val-X-Phe/Tyr (K/R-G-F/Y- 
G/A-F-V-X-F/Y), is the most highly conserved segment of 
the RNP motif (being RGFAFVEF in hCyP33); RNP-2 is 
a less well conserved hexapeptide that is rich in aromatic 
RNP-2 
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hCMP33 1 MATTKRVL%'V GGLAEEVDDK 
RBP U2 8 ERNQDATVYVGGLDEKVSEP 
12RNPI 1 MS IYV  GNLSYEVTEA 
RGP-Ia 1 MAEVEYRCFV GGLAWATTDQ 
PABP 3 220 NLYV KNINSETTDE 
RNP-I  
VLHAAFIPFG DITDIQIPLD YETEKHRGFA FVEFELAEDA 60 
LLWELFLQAG PVVNTHMPLD RVTGQHQGYG FVEFLSEEDA 67 
DLTAVFTEYG AVKRVQLPID RETGRMRGFG FVEMSADAEE 55 
TLGFJtPSQFG EILDSKIIND RETGRSRGFG FVTFKDEKAM 60 
QFQELFAKFG PIVSASLEKD ADGKL-KGFG FVNYEKHEDA 272 
hCyP33 61 AAAIDNNNES 
RBP U2 68 DYAIKIMNMI 
12RNPI 56 DAAIAALGGA 
RGP-Ia 61 RDAIEGMNGQ 
PABP 3 273 VKAVEALNDS 
b 
hCyP33 137 R SNPQVYMDI  
hCyPl8cy 1 MVNPTVFFDI  
hCyP23sec 33 KVTVKVYFDL 
hCyP22mito 43 SGNPLVYLDV 
hCyP41cy 13 PSNPRVFFDV 
hCyP158mem 58 QDRPQCHFDI 
RanBP2 3064 - - -PVVFFDV 
ELFGRTIRVN LAKP 84 
KLYGKPIRVN KASA 91 
EWMGRGLRVN KAKP 79 
DLDGRNITVN IAQS 84 
ELNGEKLYVG RAQK 296 
KIGNKPAGRI QMLLRSDVVP 
AVDGEPLGRV SFELFADK'VE 
RIGDEDVGRV IFGLFGKTVP 
DNAGKPLGLV VLELKADWP 
DIGGERVGRI VLELFADIVP 
EINREPVGRI MFQRFSDICP 
CADGEPLGRI TMELFSNIVP 
MTAENFRCLC 
KTAENFRALS 
KTVDNFVALA 
KTAENFRALC 
KTAENFRALC 
KTCKNFLCLC 
RTAENFRALC 
THEKGFG . . . . . . . . . . .  FK 185 
TGEKGFG . . . . . . . . . . .  YK  49 
TGEKGFG . . . . . . . . . . .  YK  81 
TGEKGFG . . . . . . . . . . .  YK  91 
TGEKGFG... HTTGKPLHFK 69 
SGEKGIGHTT KTTGKKLCYK 117 
TGEKGFG . . . . . . . . . . .  FK 3109 
hCyP33 186 
hCyPl8cy 50 
hCyP23sec 82 
hCyP22mito 92 
hCyP41cy 70 
hCyP158mem 118 
RanBP2 3110 
GSSFHRI IPQ 
GSCFHRI IPG 
NSKFHRVIKD 
GSTFHRVIPS  
GCPFHRIIKK 
GSTFHRVVKN 
NSIPHRVIPD 
~ N HNGTGGKSIY  R HNGTC, GKSIY 
FMI~GGD~TR GDGTGGKSIY 
F~I~GI)D~sR NHGTC, GKSIY 
N QNGTGGKSIY  
FMIpGGD~SE GNGKGGESIY  
FVC~IGD~TK HDG'IW~QSIY 
GKKFDDENFI  
GEKFEDENFI  
GERFPDENFK 
GSPFRDENFT 
GEKFEDENFH 
GGYEKDENFI  
GDKFEDENFD 
LKHTGPGLLS MANSGPNTNG 245 
LKHTGPGILS  MANAGPNTNG 109 
LKHYGPGVLS MANAGKDTNG 141 
LI~IVGPGVLS MANAGPNTNG 151 
YKHDLEGLLS MANAGRNTNG 129 
LKHDRAFLLS  MANAGKHTNG 177 
VKIITGPGLLS MANQGQNTNN 3169 
hCyP33 246 SQFFLTCDKT DWL~~VTEGLDVL 275 
hCyPl8cy II0 SQFFICTAKT ~ 6 ~VKEGMNIV 139 
hCyP23sec 142 SQFFITIVKT A ~  G EVLEGMEVV 161 
hCyP22mito 152 SQFFICTIKT ~ ~ ~ D  G T%'KEGMIY4V 171 
hCyP41cy 130 SQFFITTVPT ~VIEGIGVA 159 
hCyP158mem 178 SQFFITTKPA PHLD~VlCV~F G3VISGFIVI 207 
RanBP2 3170 SQPVITLKKA EHLD~. ,~ 'KDGMDTV 3199 
Fig. 2. Sequence omparisons of the RNA-binding domain (a) and PPIase (cyclophilin) domain (b) of hCyP33, a: Alignment of amino acids 1- 
84 of hCyP33 with RNA-binding domains (RNP-2 and RNP-1) of the following proteins: RBP U2, human spliceosome-associated protein 
SAP 49 [29]; Synechococcus 12 RNP1 [23]; RGP-la, an RNA-binding protein in wood tobacco [30] and PABP 3, a yeast poly(A)-binding pro- 
tein [31]. The region of two conserved motifs of RNA-binding proteins, RNP-2 and RNP-1 are indicated, b: Alignment of amino acids 137- 
275 of hCyP33 with the PPIase domains of different cyclophilins: hCypl8cy, human cytosolic yclophilin A [13]; hCyP23sec, human secreted 
cyclophilin B [19]; hCyP22mito, human mitochondrial cyclophilin [20]; hCyP41cy, a human cyclophilin present in hormone receptor complexes 
[32]; hCyP158mem, a plasma membrane cyclophilin of human natural killer cells [18]; RanBP2, a Ran/TC4-binding nucleopore protein [17]. 
The regions used for initial design of PCR primers to identify hCyP33 are boxed. Identical amino acids are printed in bold type in a and b. 
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Fig. 3. hCyP33 is a low abundance nuclear protein in human T 
cells, a: Detection of hCyp33 mRNA using Northern hybridization. 
Human Jurkat T cell poly(A) + RNA (2 Ixg per lane) was hybridized 
to part of the eDNA of hCyP33 (corresponding to amino acid se- 
quence 1-152; lane 1) or the eDNA coding for hCyPl8 [13] (lane 
2). Exposure times of the autoradiographic films were 2 h for 
hCyP18 mRNA (lane 2), and 7 days for hCyP33 mRNA (lane 1). 
b: Immunoblot of different cellular fractions from the human Jurkat 
T cell line using affinity-purified anti-hCyP33 rabbit antibodies. Jur- 
kat T cells were subfractionated according to [21]; lane 1, 12 000 x g 
supernatant of nuclear free cell extract, 2, 12000 xg pellet of nucle- 
ar free cell extract, 3, 12000×g supernant of nuclear extract, 4, 
12000Xg pellet of nuclear extract. The polyclonal rabbit antiserum 
was obtained by immunisation of a glutathione transferase fusion 
protein [22] containing amino acids 67-164 of hCyP33 at the car- 
boxyterminus. 
! 
and aliphatic amino acids [27] (LYVGGL in hCyP33). In 
addition, several other amino acids throughout the RNP mo- 
tif are conserved, when other RNA-binding proteins are com- 
pared (see Fig. 2a). The human protein whose RNA-binding 
domain is most closely related (43.8% identity in a 73 amino 
acid overlap) to the hCyP33 RNA-binding domain is the spli- 
ceosome-associated protein SAP49 (RBP U2 [29]). Other pro- 
teins in the identity range of 40% can be found in cyanobac- 
teria (12 RNP1 [23]), an RNA-binding protein from tobacco 
(RGP-1 [30]) and a yeast poly(A)-binding protein (PABP3 
[31]). Despite their different functions, these proteins all share 
this RNA-binding domain. This domain is typical for a large 
family of RNA-binding proteins like snRNP proteins, hnRNP 
proteins and other proteins regulating RNA processing or 
translation [25-27]. 
In addition to this putative RNA-binding domain, hCyP33 
contains a typical cyelophilin domain (Fig. 2b), which is 70% 
identical to cytosolic hCyP18 [13], a protein probably involved 
in protein folding (like Neurospora crassa cytosolic and mito- 
chondrial NcCyP20 [7,14,28], E. Zimmermann and M. 
Tropschug, unpublished ata) and stabilization [10,11]. 
Cytosolic hCyP18 is an abundant protein. We used its 
eDNA [13] as a control probe in a Northern blot analysis 
(Fig. 3a, lane 2), which showed its abundant hCyP18 
mRNA (0.8 kb); using hCyP33 eDNA as a probe, we recog- 
nized a rare mRNA of 1.6 kb (Fig. 3a, lane 1), in the range of 
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approximately 1/1000 the amount of hCyP18 mRNA. Since 
the longest hCyP33 eDNA isolated was 1.6 kb long, we con- 
elude that we have cloned a full-length cDNA (see also be- 
low). 
For antibody production, a GST fusion protein [22] was 
constructed containing the interconnecting region (amino 
acids 67-164; see schematic representation in Fig. lb) between 
the RNA-binding and the PPIase domain (to avoid cross-re- 
activity of the antiserum with other CyPs and/or RNA-bind- 
ing proteins). Polyelonal antibodies were raised in rabbits 
against the fusion protein and affinity-purified. Jurkat cells 
were fractionated into nuclei and nuclear-free fractions [21]. 
These fractions were tested for the presence of hCyP33 in a 
Western blot analysis. Only nuclear soluble and nuclear insol- 
uble (matrix) fractions howed the presence of a protein with 
an apparent molecular weight of 33 kDa (Fig. 3b, lanes 3 and 
4 respectively). We conclude that hCyP33 is a nuclear protein 
in Jurkat cells and that we have indeed cloned a full-length 
cDNA coding for this protein (see above). 
Using a coupled transcription/translation system (TNT ly- 
sate; Promega), the protein was expressed in vitro from the 
eDNA cloned into pGEM4. After translation using 
[35S]methionine as label, total translation products were sepa- 
rated on SDS gels. Fig. 4a (lane 1) shows the result of an in 
vitro expression experiment. Two major bands with apparent 
molecular weights of 33 kDa and 30 kDa showed up, the 
upper band running exactly at the same position in SDS- 
PAGE as hCyP33 in Western blots (see Fig. 3b, lanes 3, 4). 
Since both proteins are coded by the same cDNA, we suggest 
that the 33/30 kDa proteins reflect different forms (e.g. post- 
translational modifications) of hCyP33. RNA-binding pro- 
teins are often phosphorylated in vivo [26,27]. Specific anti- 
serum raised against hCyP33 (see Fig. lb) precipitated both 
the 33 kDa and 30 kDa proteins from the reticulocyte lysate 
with equal efficiency (Fig. 4a, lane 2), showing that both pro- 
teins are hCyP33 related. The nature of the differences in both 
isoforms of hCyP33 are unknown to date. 
We used in vitro expressed hCyP33 to test whether the 
putative RNA-binding domain (Fig. lbFig. 2a) is functional. 
Reticulocyte lysate containing [35S]methionine-labeled hCyP33 
was incubated with agarose-coupled nucleic acids. Very weak 
binding was observed using single-stranded (ss) DNA and 
double-stranded ( s) DNA. Almost no binding was observed 
using poly(C) or poly(G) columns. In contrast, specific bind- 
ing was observed on poly(A) and poly(U) columns (see Fig. 
4b), suggesting that hCyP33 is indeed an RNA-binding pro- 
tein with a strong preference for A and U residues. It is 
interesting to note that only the 33 kDa band produced in 
reticulocyte lysates was able to bind. This could mean that a 
posttranslational modification is necessary for efficient bind- 
ing to RNA. Phosphorylation and dephosphorylation of
RNA-binding proteins are known to play an important role 
in regulation of the activities of these proteins [27]. 
To test whether the CyP domain (Fig. 2b) of hCyP33 is 
functional as well and therefore exhibits PPIase activity, a 
glutathione transferase fusion protein [22] containing 
hCyP33 at the carboxy-terminus was expressed in E. coli, 
purified using glutathione beads and tested in a peptide- 
coupled PPIase assay [24]. 
Indeed, this protein exhibits PPIase activity which can be 
inhibited by cyclosporin A (CsA; see Fig. 4c). The enzymatic 
activity of hCyP33 in terms of Km/Keat values is similar to that 
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Fig. 4. Both the RNA-binding domain and the CyP domain are functional, a: Expression in vitro and antibody precipitation of hCyP33. A 
full-length cDNA coding for hCyp33 was subcloned into pGEM4. Coupled in vitro transcription/translation usi g [a~S]methionine as label was 
performed in a TNT/SP6 coupled reticulocyte lysate system (Promega) (lane 1). In order to confirm that the major bands appearing in lane 1 
are related to hCyP33, immunoprecipitation using anti-hCyP33 antiserum was performed (lane 2). b: Nucleic acid binding assays were per- 
formed using aSS-labeled hCyP33 from the in vitro expression system (see a, lane 1) as described [23]. Binding was monitored on single- 
stranded (ss) DNA, double-stranded (ds) DNA, poly(A), poly(C), poly(G) and poly(U), respectively, covalently bound to agarose, c: hCyP33 is 
active as a CsA-sensitive PPIase. Assays of PPIase activity of hCyP33: • blank, • 17 nM GST-hCyP33, [] 17 nM GST-hCyP33 preincubated 
with CsA. Assays were performed in a standard peptide assay [24] using purified GST-hCyP33 and Suc-Ala-Ala-Pro-Phe-pNA as a substrate. 
17 prnol of GST-hCyP33 (+ 1.70 nmol CsA) was preincubated at 10°C with 800 p.g/ml chymotrypsin for 5 min in a volume of 995 ktl. The as- 
say was started by the addition of 5 ktl of a 8 mM stock of the substrate. After mixing, the increase in absorbance at 390 nm was monitored. 
H. Mi et al.IFEBS Letters 398 (1996) 201-205 205 
of hCyP18 (data not shown). In addition to the peptide 
PPIase assay, we also tested whether hCyP33 is active as a 
true protein-folding enzyme. Using refolding of urea-dena- 
tured mouse dihydrofolate r ductase (DHFR) as a model sys- 
tem [7,8], we found that hCyP33 accelerates DHFR refolding; 
this protein folding activity was in the same range as that for 
hCyP18 (data not shown) or Neurospora crassa NcCyP20 [7]. 
The enzymatic activities of all three cyclophilins were inhib- 
ited by CsA. 
In summary, hCyP33 represents a novel nuclear T cell pro- 
tein, which combines RNA binding and PPIase activities in 
the same molecule. 
4. Discussion 
Why might nature combine RNA binding and PPIase ac- 
tivity in one molecule? Known PPIases can play a dual role in 
protein folding and cellular signalling [15]. 
hCyP33 could be a regulatory protein which after binding 
to a specific RNA might bind another protein and perhaps 
stabilize or alter the folding state of this protein. This protein 
could in turn affect RNA metabolism, hCyP33 could have a 
function similar to hCyP40 which is present in nonactive ster- 
oid receptor complexes [9]. Transient interactions between 
PPIases and target proteins are known, as between hCyP18 
and the gag protein of HIV. Disruption of this complex by 
CsA or mutations of critical prolyl residues in gag leads to 
defective virions [10, i 1]. Another example of a transient inter- 
action between a cyclophilin and a target protein is the inter- 
action between DmCyP26 (the ninaA gene product of Droso- 
phila melanogaster), a CyP homolog present in the 
endoplasmic reticulum, and Rh-1 rhodopsin. DmCyP26 func- 
tions like a chaperone, forming a stable complex at least in the 
maturation process of rhodopsin [12]. 
hCyP33 could influence RNA processing, modification, 
transport or translation, either by itself or when bound to 
another factor. In this context, it is interesting to note that 
there exists a novel family of PPIases, the parvulin family [34], 
members of which are essential for regulation of human mi- 
tosis (Pinl [33]) and for RNA maturation in yeast (Ptfl [35]; 
H. Domdey and G. Fischer, personal communication). It is 
tempting to speculate that PPIases play not only a role in 
protein folding after protein synthesis or after proteins have 
crossed biological membranes but could also act as on/off 
switches due to cis/trans isomerization of regulatory proteins. 
It will be of major interest o investigate which RNA(s) 
and/or protein(s) bind to hCyP33. A further question is how 
CsA, which acts as an immunosuppressant by suppressing 
transcription of specific T cell proteins, might influence these 
interactions. 
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